
TT Vaccine Injection
| Product/Composition | TT Vaccine Injection |
|---|---|
| Form | Injection |
| Strength | 10ml |
| Production Capacity | 1 Million Injection/Month |
| Package Insert/Leaflet | Available upon request |
TT Vaccine Injection (Tetanus Toxoid)
Category: Vaccine
Form: Injectable solution (intramuscular)
Uses:
-
Provides protection against tetanus, a serious bacterial infection caused by Clostridium tetani.
-
Administered to prevent tetanus after injury, especially puncture wounds, burns, or contaminated wounds.
-
Given as part of routine immunization schedules to maintain immunity in children and adults.
-
Used as a booster every 10 years in adults to maintain immunity.
Mechanism of Action:
-
Contains inactivated tetanus toxin (toxoid).
-
Stimulates the immune system to produce antibodies without causing disease.
-
On exposure to Clostridium tetani, the body can neutralize the toxin, preventing the development of tetanus.
Administration:
-
Given intramuscularly, typically in the upper arm (deltoid) or thigh (for infants).
-
May be given as a single dose or booster depending on age and immunization history.
Side Effects:
-
Mild pain, redness, or swelling at the injection site.
-
Low-grade fever or fatigue may occur.
-
Rare: severe allergic reaction (anaphylaxis) or neurological reactions.
Precautions:
-
Avoid in individuals with severe allergic reaction to a previous dose.
-
Use with caution in moderately or severely ill patients.
-
Ensure proper storage and handling to maintain vaccine potency.
Summary:
The TT Vaccine Injection is a tetanus toxoid vaccine used to prevent tetanus by stimulating antibody production against the tetanus toxin. It is administered intramuscularly, either as part of routine immunization or as a booster after injury. It is generally safe, with mild injection site reactions or fever being the most common side effects.